GlassScriptPrepare for your visit
Jamie Yeager
Dallas, TX · NPI 1427589803
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$5,322.34
in general payments reported to CMS, 2019-2025 · $1,556 in 2025
The $1,556 reported for 2025 was more than what 92% of providers received nationally.
Who reported paying
General payments only, top 6 by amount.
- Regeneron Healthcare Solutions, INC. $889.71
- Astrazeneca Pharmaceuticals LP $848.56
- Glaxosmithkline, LLC. $730.80
- Genzyme Corporation $647.01
- Takeda Pharmaceuticals U.S.A., INC. $242.42
- Abbvie INC. $238.59
Drugs and devices associated with these payments
Dupixent Tezspire Octagam Immune Globulin (Human) Trelegy Ellipta Nucala Panzyga Cutaquig Rinvoq Fasenra Xolair Ruconest Xembify
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Jamie Yeager listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/8806639/jamie-yeager